Stephen demonstrated that combined immunotherapy with respiratory hyperoxia can reduce tumor hypoxia and attenuate hypoxic/HIF‐1α/A2 adenosine immunosuppression, thereby exerting a powerful antitumor effect.306. The gene discussed is HIF1A; the disease is neoplasm.